PRATIK MODI: Open Payments
NPI 1992133433 · AUGUSTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$307 in 16 payments from 9 companies in 2025. Trend: 2023 $215 · 2024 $1,044 · 2025 $307
Food & beverage: $307
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 2 | $58 |
| Teva Pharmaceuticals USA, Inc. | 3 | $50 |
| UCB, Inc. | 2 | $47 |
| Lilly USA, LLC | 2 | $38 |
| Amneal Pharmaceuticals LLC | 2 | $34 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $29 |
| Merz Pharmaceuticals, LLC | 1 | $21 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
| Janssen Biotech, Inc. | 1 | $15 |
Products named: INGREZZA, AUSTEDO XR, Zilbrysq, KISUNLA, CREXONT, HYQVIA, INBRIJA, WAINUA.
Industry payments across GA — which companies pay providers there.
